Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner bought 375,000 shares of the stock in a transaction on Thursday, November 14th. The shares were acquired at an average price of A$0.08 ($0.05) per share, with a total value of A$30,000.00 ($19,607.84).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
See Also
- Five stocks we like better than Percheron Therapeutics
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- How to Invest in the Best Canadian Stocks
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
